Related Experiment Videos
[Clinico-radiological correlation in thalassemia intermedia]
G Sergiacomi1, E Palma, P Cianciulli
1Istituto di Radiologia, Università degli Studi di Roma Tor Vergata, Ospedale S. Eugenio, Roma.
La Radiologia Medica
|May 1, 1993
Summary
In thalassemia intermedia, increased serum transferrin directly correlates with larger ectopic erythropoiesis masses and worsening bone lesions, especially in transfusion-dependent patients. This highlights transferrin as a key indicator of disease progression.
Area of Science:
- Hematology
- Radiology
- Biochemistry
Background:
- Thalassemia intermedia presents significant challenges due to extramedullary hematopoiesis.
- Assessing the extent and impact of ectopic erythropoiesis is crucial for patient management.
Purpose of the Study:
- To correlate quantitative CT-assessed ectopic erythropoiesis with serum markers (erythropoietin, transferrin receptor) in thalassemia intermedia.
- To evaluate changes in ectopic erythropoiesis and bone lesions over 36 months in transfused and non-transfused patients.
Main Methods:
- Total body CT scans were used to calculate the volume of ectopic erythropoiesis foci via a digital algorithm (ROI volume).
- Serum levels of erythropoietin (EPO) and transferrin receptors (TfR) were measured.
- Clinical and radiological findings were compared over a 36-month follow-up.
Main Results:
- A direct correlation was found between serum transferrin levels and the volume of ectopic erythropoietic masses in transfusion-dependent patients.
- Increased serum transferrin corresponded to enlarged erythropoiesis masses and worsening bone lesions.
- Quantitative CT measures provided insights into disease progression.
Conclusions:
- Serum transferrin is a significant indicator of ectopic erythropoiesis burden and bone disease progression in transfusion-dependent thalassemia intermedia.
- Quantitative CT assessment of ectopic erythropoiesis is valuable for monitoring disease.
- Further research into TfR and EPO correlations is warranted.